Skip to main navigation menu Skip to main content Skip to site footer

Extrapulmonary tuberculosis. A perspective from a third-level hospital

Tuberculosis extrapulmonar. Una perspectiva desde un hospital de tercer nivel




Section
Research article

How to Cite
Extrapulmonary tuberculosis. A perspective from a third-level hospital.
rev. colomb. neumol. [Internet]. 2013 Mar. 25 [cited 2024 Nov. 22];25(1). Disponible en: https://doi.org/10.30789/rcneumologia.v25.n1.2013.129

Dimensions
PlumX
license

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Manuel C. Pacheco Gallego, MD.
    Carlos Awad, MD.
      Gerson Arias, MD.
        Paulina Ojeda, MD.
          Manuel A. Garay, MD.

            Manuel C. Pacheco Gallego, MD.,

            Internista, Neumólogo. Hospital Santa Clara. Bogotá, Colombia.

            Carlos Awad, MD.,

            Internista, Neumólogo. Hospital Santa Clara. Bogotá, Colombia.

            Gerson Arias, MD.,

            Internista, Infectólogo. Hospital Santa Clara. Bogotá, Colombia.

            Paulina Ojeda, MD.,

            Patóloga. Hospital Santa Clara. Bogotá, Colombia

            Manuel A. Garay, MD.,

            internista, Neumólogo. Hospital Santa Clara. Bogotá, Colombia.

            Antonio Lara, MD.,

            Internista, Neumólogo. Hospital Santa Clara. Bogotá, Colombia.

            Liliana Arias, MD.,

            Radióloga. Hospital Santa Clara. Bogotá, Colombia.


            Introduction: the prevalence of tuberculosis (TB) continues to be high, and shows an important increase in patients with HIV/AIDS. The relevance of extrapulmonary forms of the disease has likewise become increasingly greater. Approximately 9 million new cases of tuberculosis are reported every year, with more than one and a half million deaths due to the disease during the same period of time.

            Objectives: to evaluate and present the data of a third-level hospital with regard to extrapulmonary tuberculosis, and to give some general recommendations for its diagnosis and treatment. 

            Design, Materials and Methods: the clinical charts and the epidemiologic databases of the tuberculosis program carried out over the past 12 years at a third-level hospital of Bogotá, Colombia (Hospital Santa Clara E.S.E.) were evaluated, and a review of the literature concerning tuberculosis and its extrapulmonary presentation was carried out.

            Results: The consolidated data of cases of extrapulmonary tuberculosis among the population of the Hospital Santa Clara E.S.E. over a 12-year period: 30% of extrapulmonary cases were found in non-HIV/AIDS-infection patients and 47% in patients with AIDS. The most common forms of extrapulmonary presentation were: of the lymph nodes, of the central nervous system, and of the miliary type.

            Conclusions: An important incidence of extrapulmonary cases was found. The challenge with regard to extrapulmonary tuberculosis lies on clinical suspicion and on the selection of the method for diagnostic confirmation. These forms are paucibacillary and not very contagious, but can produce high morbidity and mortality rates, especially in patients with HIV/AIDS.


            Article visits 1290 | PDF visits 1814


            Downloads

            Download data is not yet available.
            1. Elder NC. Extrapulmonary tuberculosis. A review. Arch Fam Med. 1992; 1: 91-98.
            2. Carvalho F. de M. Predicción de la tuberculosis. BMC Public Health. 2006; 6: 43-43.
            3. Plan estratégico Colombia libre de tuberculosis 2010-2015. Ministerio de Protección Social. Disponible en: http://www.paho.org/col/index.php?option=com_content&view
            4. =article&id=431:plan-estrategico-colombia-libre-de-tuberculosis-
            5. -2015 &catid=686&Itemid=361.
            6. Ayles KH. How can we reduce TB deaths? Int J Tuberc Lung Dis. 2007; 11: 827.
            7. Sharma SK, Mohan A, Kadhiravan T. HIV-TB co-infection: Epidemiology, diagnosis and management. Indian J Med Res. 2005; 121: 550-67.
            8. Vendramini S, Villa T, Santos M, Gazetta C. Current epidemiological aspects of tuberculosis and the impact of the DOTS strategy in disease control. Rev Latino-Am Enfermagem. 2007; 15: 171-173.
            9. Castiblanco CA, Ribón W. Coinfección de tuberculosis en pacientes con VIH/SIDA: un análisis según las fuentes de información en Colombia. Infectio. 2006; 10: 232-242.
            10. Caminero JA, Rodríguez de Castro F, González A, Fernández JM, Juliá G, Cabrera P. Tuberculosis. 2011; 26: 23-27.
            11. Global burden of tuberculosis: estimated incidence, prevalence and mortality by country. World Health Organization Global Surveillance and Monitoring Project. J Am Med Assoc. 1999; 282: 677-86.
            12. Caminero JA, Rodríguez de Castro F, González A, Fernández JM, Juliá G, Cabrera P. Tuberculosis. 2011; 26: 45-66.
            13. Fuentes J, Villamil N. Factores asociados a tuberculosis extrapulmonar en Bogotá D.C.. Trabajo de Tesis para optar al título de Especialista en Epidemiología. Bogotá: Universidad Colegio Mayor de Nuestra Señora del Rosario; 2005-2008.
            14. Yew WW, Lee J. Pathogenesis of cervical tuberculous lymphadenitis: pathways to apical localization. Tuber Lung Dis. 1995; 76: 275-276.
            15. Handa U, Mundi I, Mohan S. Review article on tuberculous lymphadenitis. J Infect Dev Ctries. 2012; 6: 6-12.
            16. Caminero J A, Rodríguez de Castro F, González A, Fernández JM, Juliá G, Cabrera P. Tuberculosis. 2011; 26: 28-44.
            17. Kumar A. Lymph node tuberculosis. In: Sharma SK, Mohan A. (eds). Tuberculosis. 2nd. ed. New Delhi: Jaypee Brothers Medical Publishers; 2009. p. 397-409.
            18. C herian A, Thomas SV. Central nervous system tuberculosis. Afr Health Sci. 2011; 11: 116-27.
            19. Phypers M, Harris T, Power C. CNS tuberculosis: a longitudinal analysis of epidemiological and clinical features. Int J Tuberc Lung Dis. 2006; 10: 99-103.
            20. Thwaites GE, Tran TH. Tuberculous meningitis: many questions, too few answers. Lancet Neurol. 2005; 4: 160-70.
            21. Ahuja GK, Mohan KK, Prasad K, Behari M. Diagnostic criteria for tuberculous meningitis and their validation. Tubercle Lung Dis. 1994; 75: 149-52.
            22. Berger JR. Tuberculous meningitis. Curr Opin Neurol. 1994; 7: 191-200.
            23. Pai M, Flores LL, Pai N, Hubbard A, Riley LW, Colford JM. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2003; 3: 633-43.
            24. Rock RB, Olin M, Baker CA, Molitor TW, Peterson PK. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev. 2008; 21: 243-61.
            25. Sharma SK, Mohan A, Sharma A, Mitra DK, Alladi M. Miliary tuberculosis: new insights into an old disease. Lancet Infect Dis. 2005; 5: 415-30.
            26. Hussain SF, Irfan M, Abbasi M, et al. Clinical characteristics of 110 miliary tuberculosis patients from a low HIV prevalence country. Int J Tuberc Lung Dis. 2004; 8: 493-99.
            27. Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S, Dawson R, et al. Xpert MTB/RIF versus sputum smear microscopy: microscopy needs a level playing Field. Am J Respir Crit Care Med. 2011; 184: 132-140.
            28. Lawn, SD. Zumla, AI. Diagnosis of extrapulmonary tuberculosis using the Xpert® MTB/RIF assay. Expert Rev. Anti Infect Ther. 2012; 10: 631-635.
            29. Clemente MG. Accuracy of the Xpert MTB/RIF test for rapid diagnosis of extrapulmonary tuberculosis. Am J Respir Crit Care Med. 2012; 185: A4717.
            30. Caminero J A, Rodríguez de Castro F, González A, Fernández J M, Juliá G, Cabrera P. Tuberculosis. 2011; 26: 66-72.
            31. Laso BM. Meningitis tuberculosa: claves para su diagnóstico y propuestas terapéuticas. Rev Chil Infectol. 2011; 28: 238-247.
            32. American Thoracic Society, Centers for Disease Control and Prevention and Infectious Diseases Society of America. Treatment of Tuberculosis. MMWR. 2003; 52: 1-88.
            Sistema OJS 3.4.0.7 - Metabiblioteca |